These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 19489232

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
    Chitemerere M, Andersen TI, Holm R, Karlsen F, Børresen AL, Nesland JM.
    Breast Cancer Res Treat; 1996; 41(2):103-9. PubMed ID: 8944328
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ.
    Cancer Res; 2006 May 15; 66(10):5278-86. PubMed ID: 16707453
    [Abstract] [Full Text] [Related]

  • 6. Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy.
    Ottesen GL, Christensen IJ, Larsen JK, Larsen J, Baldetorp B, Linden T, Hansen B, Andersen J.
    Breast Cancer Res Treat; 2000 Apr 15; 60(3):219-26. PubMed ID: 10930109
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Transplantation of human primary in-situ and invasive breast carcinoma in nude mice].
    He L, Andersen JA.
    Zhonghua Zhong Liu Za Zhi; 1996 Sep 15; 18(5):321-3. PubMed ID: 9387265
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of aberrant gene expression during breast ductal carcinoma in situ progression to invasive ductal carcinoma.
    Song G, He L, Yang X, Yang Y, Cai X, Liu K, Feng G.
    J Int Med Res; 2020 Jan 15; 48(1):300060518815364. PubMed ID: 30712460
    [Abstract] [Full Text] [Related]

  • 15. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor.
    Nielsen BS, Rank F, Illemann M, Lund LR, Danø K.
    Int J Cancer; 2007 May 15; 120(10):2086-95. PubMed ID: 17290405
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN, Silverstein MJ, Galea M, Locker AP, Elston CW, Blamey RW, Ellis IO.
    Mod Pathol; 1994 Feb 15; 7(2):257-62. PubMed ID: 7911998
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative immunoprofiles of breast cancer performed by image analysis.
    Querzoli P, Albonico G, Ferretti S, Rinaldi R, Magri E, Nenci I.
    Anal Quant Cytol Histol; 1999 Apr 15; 21(2):151-60. PubMed ID: 10560485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.